Deep learning of functional perturbations from condensate morphology
Clinical Snapshot
PICO Framework
| P — Population | Cell lines (human and animal) containing biomolecular condensates, specifically the multiphase nucleolus, studied in vitro under pharmacological perturbation |
| I — Intervention | Deep-Phase framework — a neural-network-based image analysis pipeline applied to fluorescence microscopy images of condensate morphology following pharmacological and genetic perturbations (including drugs inhibiting rRNA transcription and processing, and a chemical screen identifying DNA topoisomerase inhibitors) |
| C — Comparator | Baseline/unperturbed condensate morphology; conventional morphological quantification methods; comparison across drug concentrations, time points, cell lines, and labelling techniques |
| O — Outcomes | Primary: quantification of time- and concentration-dependent structural perturbations to nucleolar sub-compartments correlated with drug potency (rRNA transcription/processing inhibition). Secondary: identification of novel nucleolar morphologies in chemical screens; discovery of DNA topoisomerase I role in rRNA processing; mechanistic insights into nucleolar sub-compartment interface maintenance; generalisability across condensate types and cell lines |
Bottom Line
Deep-Phase is a neural-network-based image analysis framework developed at Princeton University that extracts quantitative morphological signatures from fluorescence microscopy images of biomolecular condensates — specifically the multiphase nucleolus. The study demonstrates that these morphological readouts correlate with the potencies of pharmacological agents targeting ribosomal RNA transcription and processing, validating the framework against established biochemical benchmarks. In a chemical screen application, Deep-Phase identified a previously unrecognised role for DNA topoisomerase I in rRNA processing, supported by mechanistic follow-up experiments. The framework shows adaptability across cell lines, labelling strategies, and condensate types. This is a well-conceived proof-of-concept methodology paper with genuine scientific novelty. However, it is a basic science tool development study with no direct clinical applicability. Key limitations include absence of quantitative precision metrics in the abstract, single-institution origin, zero independent citations at time of publication, and no patient-derived validation. For clinicians, the relevance lies in the long-term drug discovery pipeline: if condensate morphology can reliably predict drug mechanism and potency, this platform could accelerate identification of novel therapeutic targets in oncology and other condensate-associated diseases. Independent replication is essential before broader adoption.
Key Findings
P Value: Not reported in abstract
Effect Size: Not reported in abstract; described qualitatively as 'tightly coupled' — full quantitative metrics require access to the primary paper
Primary Outcome: Deep-Phase quantifies time- and concentration-dependent structural perturbations to the multiphase nucleolus that are tightly coupled to the potencies of drugs inhibiting ribosomal RNA (rRNA) transcription and processing
Nnt Or Sensitivity: Not applicable (methodology development study); framework sensitivity to morphological perturbations is demonstrated across dose-response and time-course experiments but specific sensitivity/specificity metrics are not provided in the abstract
Confidence Interval: Not reported in abstract
Clinical Application
Implementation requires fluorescence microscopy infrastructure, computational resources for neural network deployment, and expertise in both cell biology and computational image analysis. The framework's adaptability to diverse labelling techniques (including potentially label-free approaches) may lower barriers to adoption in well-resourced research settings. Not feasible for routine clinical laboratory use in the foreseeable future No immediate relevance to PBS-listed therapeutics, TGA regulatory decisions, or RACGP clinical guidelines. Australian research institutions with condensate biology programs (e.g., WEHI, Garvan Institute, QIMR Berghofer) may find Deep-Phase relevant as a research tool. If the topoisomerase I finding is validated and extended, it could have downstream relevance to existing TGA-approved topoisomerase inhibitors (e.g., irinotecan, topotecan) used in Australian oncology practice — but this connection is highly speculative and temporally distant. No PBS or clinical practice implications at this time. Not directly applicable to patient populations at this stage. Relevant to researchers studying biomolecular condensates, nucleolar biology, and drug mechanisms in cell lines. Potential future relevance to oncology (nucleolar-targeting agents), rare disease research involving condensate dysfunction, and drug discovery programs
Abstract
Biomolecular condensates compartmentalize the interior of cells to organize complex functions, yet linking molecular interactions within condensates to their mesoscale organization remains a major challenge. To bridge this gap, we developed a neural-network-based framework-Deep-Phase (deep learning of phase-separated condensates)-that uses microscopy images to directly measure condensate morphology changes resulting from pharmacological alterations in associated biochemical processes. We use Deep-Phase to precisely quantify time- and concentration-dependent structural perturbations to the multiphase nucleolus and show that they are tightly coupled to potencies of drugs inhibiting ribosomal RNA (rRNA) transcription and processing. Applying Deep-Phase in a chemical screen, we identify a unique nucleolar morphology and discover a role for a DNA topoisomerase in rRNA processing. Mechanistic studies of this morphology provide insights into how the interfaces between nucleolar sub-compartments are maintained. We demonstrate Deep-Phase's adaptability to diverse cell lines, labeling techniques, and condensates, offering a powerful platform for connecting molecular pathways to cellular mesoscale organization.
References
- 1.Donlic, A., Comi, T. J., Quinodoz, S. A., Jaberi-Lashkari, N., Antunes Fernandes, K., Jiang, L., Wiesner, L. W., Lim, A. I., & Brangwynne, C. P. (2026). Deep learning of functional perturbations from condensate morphology. Cell. https://doi.org/10.1016/j.cell.2026.05.010
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service